Medical Care

Global Antibody Conjugation and Labeling Services Market Research Report 2025

This report aims to provide a comprehensive presentation of the global market for Antibody Conjugation and Labeling Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antibody Conjugation and Labeling Services.
The Antibody Conjugation and Labeling Services market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Antibody Conjugation and Labeling Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antibody Conjugation and Labeling Services companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
ProSci, Inc
Thermo Fisher Scientific
Abcam
Cell Signaling Technology
Bio X Cell
SouthernBiotech
Novus Biologicals
GenScript
Leinco Technologies
Standard BioTools
AlphaThera
Creative Biolabs
Antibodies
Boster Biological Technology
Cygnus Technologies
Cayman Chemical
GeneTex
ProteoGenix
Levena Biopharma
Merck
Lonza
Charles River
Beijing Abace Biotechnology
Segment by Type
Antibody Conjugation Services
Antibody Labeling Services
Segment by Application
Biotechnology
Medical
University
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Antibody Conjugation and Labeling Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antibody Conjugation and Labeling Services Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Antibody Conjugation Services
1.2.3 Antibody Labeling Services
1.3 Market by Application
1.3.1 Global Antibody Conjugation and Labeling Services Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Biotechnology
1.3.3 Medical
1.3.4 University
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antibody Conjugation and Labeling Services Market Perspective (2020-2031)
2.2 Global Antibody Conjugation and Labeling Services Growth Trends by Region
2.2.1 Global Antibody Conjugation and Labeling Services Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Antibody Conjugation and Labeling Services Historic Market Size by Region (2020-2025)
2.2.3 Antibody Conjugation and Labeling Services Forecasted Market Size by Region (2026-2031)
2.3 Antibody Conjugation and Labeling Services Market Dynamics
2.3.1 Antibody Conjugation and Labeling Services Industry Trends
2.3.2 Antibody Conjugation and Labeling Services Market Drivers
2.3.3 Antibody Conjugation and Labeling Services Market Challenges
2.3.4 Antibody Conjugation and Labeling Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antibody Conjugation and Labeling Services Players by Revenue
3.1.1 Global Top Antibody Conjugation and Labeling Services Players by Revenue (2020-2025)
3.1.2 Global Antibody Conjugation and Labeling Services Revenue Market Share by Players (2020-2025)
3.2 Global Antibody Conjugation and Labeling Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Antibody Conjugation and Labeling Services Revenue
3.4 Global Antibody Conjugation and Labeling Services Market Concentration Ratio
3.4.1 Global Antibody Conjugation and Labeling Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antibody Conjugation and Labeling Services Revenue in 2024
3.5 Global Key Players of Antibody Conjugation and Labeling Services Head office and Area Served
3.6 Global Key Players of Antibody Conjugation and Labeling Services, Product and Application
3.7 Global Key Players of Antibody Conjugation and Labeling Services, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Antibody Conjugation and Labeling Services Breakdown Data by Type
4.1 Global Antibody Conjugation and Labeling Services Historic Market Size by Type (2020-2025)
4.2 Global Antibody Conjugation and Labeling Services Forecasted Market Size by Type (2026-2031)
5 Antibody Conjugation and Labeling Services Breakdown Data by Application
5.1 Global Antibody Conjugation and Labeling Services Historic Market Size by Application (2020-2025)
5.2 Global Antibody Conjugation and Labeling Services Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Antibody Conjugation and Labeling Services Market Size (2020-2031)
6.2 North America Antibody Conjugation and Labeling Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Antibody Conjugation and Labeling Services Market Size by Country (2020-2025)
6.4 North America Antibody Conjugation and Labeling Services Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Antibody Conjugation and Labeling Services Market Size (2020-2031)
7.2 Europe Antibody Conjugation and Labeling Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Antibody Conjugation and Labeling Services Market Size by Country (2020-2025)
7.4 Europe Antibody Conjugation and Labeling Services Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Antibody Conjugation and Labeling Services Market Size (2020-2031)
8.2 Asia-Pacific Antibody Conjugation and Labeling Services Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Antibody Conjugation and Labeling Services Market Size by Region (2020-2025)
8.4 Asia-Pacific Antibody Conjugation and Labeling Services Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Antibody Conjugation and Labeling Services Market Size (2020-2031)
9.2 Latin America Antibody Conjugation and Labeling Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Antibody Conjugation and Labeling Services Market Size by Country (2020-2025)
9.4 Latin America Antibody Conjugation and Labeling Services Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antibody Conjugation and Labeling Services Market Size (2020-2031)
10.2 Middle East & Africa Antibody Conjugation and Labeling Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Antibody Conjugation and Labeling Services Market Size by Country (2020-2025)
10.4 Middle East & Africa Antibody Conjugation and Labeling Services Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 ProSci, Inc
11.1.1 ProSci, Inc Company Details
11.1.2 ProSci, Inc Business Overview
11.1.3 ProSci, Inc Antibody Conjugation and Labeling Services Introduction
11.1.4 ProSci, Inc Revenue in Antibody Conjugation and Labeling Services Business (2020-2025)
11.1.5 ProSci, Inc Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Antibody Conjugation and Labeling Services Introduction
11.2.4 Thermo Fisher Scientific Revenue in Antibody Conjugation and Labeling Services Business (2020-2025)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Abcam
11.3.1 Abcam Company Details
11.3.2 Abcam Business Overview
11.3.3 Abcam Antibody Conjugation and Labeling Services Introduction
11.3.4 Abcam Revenue in Antibody Conjugation and Labeling Services Business (2020-2025)
11.3.5 Abcam Recent Development
11.4 Cell Signaling Technology
11.4.1 Cell Signaling Technology Company Details
11.4.2 Cell Signaling Technology Business Overview
11.4.3 Cell Signaling Technology Antibody Conjugation and Labeling Services Introduction
11.4.4 Cell Signaling Technology Revenue in Antibody Conjugation and Labeling Services Business (2020-2025)
11.4.5 Cell Signaling Technology Recent Development
11.5 Bio X Cell
11.5.1 Bio X Cell Company Details
11.5.2 Bio X Cell Business Overview
11.5.3 Bio X Cell Antibody Conjugation and Labeling Services Introduction
11.5.4 Bio X Cell Revenue in Antibody Conjugation and Labeling Services Business (2020-2025)
11.5.5 Bio X Cell Recent Development
11.6 SouthernBiotech
11.6.1 SouthernBiotech Company Details
11.6.2 SouthernBiotech Business Overview
11.6.3 SouthernBiotech Antibody Conjugation and Labeling Services Introduction
11.6.4 SouthernBiotech Revenue in Antibody Conjugation and Labeling Services Business (2020-2025)
11.6.5 SouthernBiotech Recent Development
11.7 Novus Biologicals
11.7.1 Novus Biologicals Company Details
11.7.2 Novus Biologicals Business Overview
11.7.3 Novus Biologicals Antibody Conjugation and Labeling Services Introduction
11.7.4 Novus Biologicals Revenue in Antibody Conjugation and Labeling Services Business (2020-2025)
11.7.5 Novus Biologicals Recent Development
11.8 GenScript
11.8.1 GenScript Company Details
11.8.2 GenScript Business Overview
11.8.3 GenScript Antibody Conjugation and Labeling Services Introduction
11.8.4 GenScript Revenue in Antibody Conjugation and Labeling Services Business (2020-2025)
11.8.5 GenScript Recent Development
11.9 Leinco Technologies
11.9.1 Leinco Technologies Company Details
11.9.2 Leinco Technologies Business Overview
11.9.3 Leinco Technologies Antibody Conjugation and Labeling Services Introduction
11.9.4 Leinco Technologies Revenue in Antibody Conjugation and Labeling Services Business (2020-2025)
11.9.5 Leinco Technologies Recent Development
11.10 Standard BioTools
11.10.1 Standard BioTools Company Details
11.10.2 Standard BioTools Business Overview
11.10.3 Standard BioTools Antibody Conjugation and Labeling Services Introduction
11.10.4 Standard BioTools Revenue in Antibody Conjugation and Labeling Services Business (2020-2025)
11.10.5 Standard BioTools Recent Development
11.11 AlphaThera
11.11.1 AlphaThera Company Details
11.11.2 AlphaThera Business Overview
11.11.3 AlphaThera Antibody Conjugation and Labeling Services Introduction
11.11.4 AlphaThera Revenue in Antibody Conjugation and Labeling Services Business (2020-2025)
11.11.5 AlphaThera Recent Development
11.12 Creative Biolabs
11.12.1 Creative Biolabs Company Details
11.12.2 Creative Biolabs Business Overview
11.12.3 Creative Biolabs Antibody Conjugation and Labeling Services Introduction
11.12.4 Creative Biolabs Revenue in Antibody Conjugation and Labeling Services Business (2020-2025)
11.12.5 Creative Biolabs Recent Development
11.13 Antibodies
11.13.1 Antibodies Company Details
11.13.2 Antibodies Business Overview
11.13.3 Antibodies Antibody Conjugation and Labeling Services Introduction
11.13.4 Antibodies Revenue in Antibody Conjugation and Labeling Services Business (2020-2025)
11.13.5 Antibodies Recent Development
11.14 Boster Biological Technology
11.14.1 Boster Biological Technology Company Details
11.14.2 Boster Biological Technology Business Overview
11.14.3 Boster Biological Technology Antibody Conjugation and Labeling Services Introduction
11.14.4 Boster Biological Technology Revenue in Antibody Conjugation and Labeling Services Business (2020-2025)
11.14.5 Boster Biological Technology Recent Development
11.15 Cygnus Technologies
11.15.1 Cygnus Technologies Company Details
11.15.2 Cygnus Technologies Business Overview
11.15.3 Cygnus Technologies Antibody Conjugation and Labeling Services Introduction
11.15.4 Cygnus Technologies Revenue in Antibody Conjugation and Labeling Services Business (2020-2025)
11.15.5 Cygnus Technologies Recent Development
11.16 Cayman Chemical
11.16.1 Cayman Chemical Company Details
11.16.2 Cayman Chemical Business Overview
11.16.3 Cayman Chemical Antibody Conjugation and Labeling Services Introduction
11.16.4 Cayman Chemical Revenue in Antibody Conjugation and Labeling Services Business (2020-2025)
11.16.5 Cayman Chemical Recent Development
11.17 GeneTex
11.17.1 GeneTex Company Details
11.17.2 GeneTex Business Overview
11.17.3 GeneTex Antibody Conjugation and Labeling Services Introduction
11.17.4 GeneTex Revenue in Antibody Conjugation and Labeling Services Business (2020-2025)
11.17.5 GeneTex Recent Development
11.18 ProteoGenix
11.18.1 ProteoGenix Company Details
11.18.2 ProteoGenix Business Overview
11.18.3 ProteoGenix Antibody Conjugation and Labeling Services Introduction
11.18.4 ProteoGenix Revenue in Antibody Conjugation and Labeling Services Business (2020-2025)
11.18.5 ProteoGenix Recent Development
11.19 Levena Biopharma
11.19.1 Levena Biopharma Company Details
11.19.2 Levena Biopharma Business Overview
11.19.3 Levena Biopharma Antibody Conjugation and Labeling Services Introduction
11.19.4 Levena Biopharma Revenue in Antibody Conjugation and Labeling Services Business (2020-2025)
11.19.5 Levena Biopharma Recent Development
11.20 Merck
11.20.1 Merck Company Details
11.20.2 Merck Business Overview
11.20.3 Merck Antibody Conjugation and Labeling Services Introduction
11.20.4 Merck Revenue in Antibody Conjugation and Labeling Services Business (2020-2025)
11.20.5 Merck Recent Development
11.21 Lonza
11.21.1 Lonza Company Details
11.21.2 Lonza Business Overview
11.21.3 Lonza Antibody Conjugation and Labeling Services Introduction
11.21.4 Lonza Revenue in Antibody Conjugation and Labeling Services Business (2020-2025)
11.21.5 Lonza Recent Development
11.22 Charles River
11.22.1 Charles River Company Details
11.22.2 Charles River Business Overview
11.22.3 Charles River Antibody Conjugation and Labeling Services Introduction
11.22.4 Charles River Revenue in Antibody Conjugation and Labeling Services Business (2020-2025)
11.22.5 Charles River Recent Development
11.23 Beijing Abace Biotechnology
11.23.1 Beijing Abace Biotechnology Company Details
11.23.2 Beijing Abace Biotechnology Business Overview
11.23.3 Beijing Abace Biotechnology Antibody Conjugation and Labeling Services Introduction
11.23.4 Beijing Abace Biotechnology Revenue in Antibody Conjugation and Labeling Services Business (2020-2025)
11.23.5 Beijing Abace Biotechnology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Antibody Conjugation and Labeling Services Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Antibody Conjugation Services
Table 3. Key Players of Antibody Labeling Services
Table 4. Global Antibody Conjugation and Labeling Services Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Antibody Conjugation and Labeling Services Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Antibody Conjugation and Labeling Services Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Antibody Conjugation and Labeling Services Market Share by Region (2020-2025)
Table 8. Global Antibody Conjugation and Labeling Services Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Antibody Conjugation and Labeling Services Market Share by Region (2026-2031)
Table 10. Antibody Conjugation and Labeling Services Market Trends
Table 11. Antibody Conjugation and Labeling Services Market Drivers
Table 12. Antibody Conjugation and Labeling Services Market Challenges
Table 13. Antibody Conjugation and Labeling Services Market Restraints
Table 14. Global Antibody Conjugation and Labeling Services Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Antibody Conjugation and Labeling Services Market Share by Players (2020-2025)
Table 16. Global Top Antibody Conjugation and Labeling Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody Conjugation and Labeling Services as of 2024)
Table 17. Ranking of Global Top Antibody Conjugation and Labeling Services Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Antibody Conjugation and Labeling Services Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Antibody Conjugation and Labeling Services, Headquarters and Area Served
Table 20. Global Key Players of Antibody Conjugation and Labeling Services, Product and Application
Table 21. Global Key Players of Antibody Conjugation and Labeling Services, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Antibody Conjugation and Labeling Services Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Antibody Conjugation and Labeling Services Revenue Market Share by Type (2020-2025)
Table 25. Global Antibody Conjugation and Labeling Services Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Antibody Conjugation and Labeling Services Revenue Market Share by Type (2026-2031)
Table 27. Global Antibody Conjugation and Labeling Services Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Antibody Conjugation and Labeling Services Revenue Market Share by Application (2020-2025)
Table 29. Global Antibody Conjugation and Labeling Services Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Antibody Conjugation and Labeling Services Revenue Market Share by Application (2026-2031)
Table 31. North America Antibody Conjugation and Labeling Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Antibody Conjugation and Labeling Services Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Antibody Conjugation and Labeling Services Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Antibody Conjugation and Labeling Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Antibody Conjugation and Labeling Services Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Antibody Conjugation and Labeling Services Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Antibody Conjugation and Labeling Services Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Antibody Conjugation and Labeling Services Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Antibody Conjugation and Labeling Services Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Antibody Conjugation and Labeling Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Antibody Conjugation and Labeling Services Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Antibody Conjugation and Labeling Services Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Antibody Conjugation and Labeling Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Antibody Conjugation and Labeling Services Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Antibody Conjugation and Labeling Services Market Size by Country (2026-2031) & (US$ Million)
Table 46. ProSci, Inc Company Details
Table 47. ProSci, Inc Business Overview
Table 48. ProSci, Inc Antibody Conjugation and Labeling Services Product
Table 49. ProSci, Inc Revenue in Antibody Conjugation and Labeling Services Business (2020-2025) & (US$ Million)
Table 50. ProSci, Inc Recent Development
Table 51. Thermo Fisher Scientific Company Details
Table 52. Thermo Fisher Scientific Business Overview
Table 53. Thermo Fisher Scientific Antibody Conjugation and Labeling Services Product
Table 54. Thermo Fisher Scientific Revenue in Antibody Conjugation and Labeling Services Business (2020-2025) & (US$ Million)
Table 55. Thermo Fisher Scientific Recent Development
Table 56. Abcam Company Details
Table 57. Abcam Business Overview
Table 58. Abcam Antibody Conjugation and Labeling Services Product
Table 59. Abcam Revenue in Antibody Conjugation and Labeling Services Business (2020-2025) & (US$ Million)
Table 60. Abcam Recent Development
Table 61. Cell Signaling Technology Company Details
Table 62. Cell Signaling Technology Business Overview
Table 63. Cell Signaling Technology Antibody Conjugation and Labeling Services Product
Table 64. Cell Signaling Technology Revenue in Antibody Conjugation and Labeling Services Business (2020-2025) & (US$ Million)
Table 65. Cell Signaling Technology Recent Development
Table 66. Bio X Cell Company Details
Table 67. Bio X Cell Business Overview
Table 68. Bio X Cell Antibody Conjugation and Labeling Services Product
Table 69. Bio X Cell Revenue in Antibody Conjugation and Labeling Services Business (2020-2025) & (US$ Million)
Table 70. Bio X Cell Recent Development
Table 71. SouthernBiotech Company Details
Table 72. SouthernBiotech Business Overview
Table 73. SouthernBiotech Antibody Conjugation and Labeling Services Product
Table 74. SouthernBiotech Revenue in Antibody Conjugation and Labeling Services Business (2020-2025) & (US$ Million)
Table 75. SouthernBiotech Recent Development
Table 76. Novus Biologicals Company Details
Table 77. Novus Biologicals Business Overview
Table 78. Novus Biologicals Antibody Conjugation and Labeling Services Product
Table 79. Novus Biologicals Revenue in Antibody Conjugation and Labeling Services Business (2020-2025) & (US$ Million)
Table 80. Novus Biologicals Recent Development
Table 81. GenScript Company Details
Table 82. GenScript Business Overview
Table 83. GenScript Antibody Conjugation and Labeling Services Product
Table 84. GenScript Revenue in Antibody Conjugation and Labeling Services Business (2020-2025) & (US$ Million)
Table 85. GenScript Recent Development
Table 86. Leinco Technologies Company Details
Table 87. Leinco Technologies Business Overview
Table 88. Leinco Technologies Antibody Conjugation and Labeling Services Product
Table 89. Leinco Technologies Revenue in Antibody Conjugation and Labeling Services Business (2020-2025) & (US$ Million)
Table 90. Leinco Technologies Recent Development
Table 91. Standard BioTools Company Details
Table 92. Standard BioTools Business Overview
Table 93. Standard BioTools Antibody Conjugation and Labeling Services Product
Table 94. Standard BioTools Revenue in Antibody Conjugation and Labeling Services Business (2020-2025) & (US$ Million)
Table 95. Standard BioTools Recent Development
Table 96. AlphaThera Company Details
Table 97. AlphaThera Business Overview
Table 98. AlphaThera Antibody Conjugation and Labeling Services Product
Table 99. AlphaThera Revenue in Antibody Conjugation and Labeling Services Business (2020-2025) & (US$ Million)
Table 100. AlphaThera Recent Development
Table 101. Creative Biolabs Company Details
Table 102. Creative Biolabs Business Overview
Table 103. Creative Biolabs Antibody Conjugation and Labeling Services Product
Table 104. Creative Biolabs Revenue in Antibody Conjugation and Labeling Services Business (2020-2025) & (US$ Million)
Table 105. Creative Biolabs Recent Development
Table 106. Antibodies Company Details
Table 107. Antibodies Business Overview
Table 108. Antibodies Antibody Conjugation and Labeling Services Product
Table 109. Antibodies Revenue in Antibody Conjugation and Labeling Services Business (2020-2025) & (US$ Million)
Table 110. Antibodies Recent Development
Table 111. Boster Biological Technology Company Details
Table 112. Boster Biological Technology Business Overview
Table 113. Boster Biological Technology Antibody Conjugation and Labeling Services Product
Table 114. Boster Biological Technology Revenue in Antibody Conjugation and Labeling Services Business (2020-2025) & (US$ Million)
Table 115. Boster Biological Technology Recent Development
Table 116. Cygnus Technologies Company Details
Table 117. Cygnus Technologies Business Overview
Table 118. Cygnus Technologies Antibody Conjugation and Labeling Services Product
Table 119. Cygnus Technologies Revenue in Antibody Conjugation and Labeling Services Business (2020-2025) & (US$ Million)
Table 120. Cygnus Technologies Recent Development
Table 121. Cayman Chemical Company Details
Table 122. Cayman Chemical Business Overview
Table 123. Cayman Chemical Antibody Conjugation and Labeling Services Product
Table 124. Cayman Chemical Revenue in Antibody Conjugation and Labeling Services Business (2020-2025) & (US$ Million)
Table 125. Cayman Chemical Recent Development
Table 126. GeneTex Company Details
Table 127. GeneTex Business Overview
Table 128. GeneTex Antibody Conjugation and Labeling Services Product
Table 129. GeneTex Revenue in Antibody Conjugation and Labeling Services Business (2020-2025) & (US$ Million)
Table 130. GeneTex Recent Development
Table 131. ProteoGenix Company Details
Table 132. ProteoGenix Business Overview
Table 133. ProteoGenix Antibody Conjugation and Labeling Services Product
Table 134. ProteoGenix Revenue in Antibody Conjugation and Labeling Services Business (2020-2025) & (US$ Million)
Table 135. ProteoGenix Recent Development
Table 136. Levena Biopharma Company Details
Table 137. Levena Biopharma Business Overview
Table 138. Levena Biopharma Antibody Conjugation and Labeling Services Product
Table 139. Levena Biopharma Revenue in Antibody Conjugation and Labeling Services Business (2020-2025) & (US$ Million)
Table 140. Levena Biopharma Recent Development
Table 141. Merck Company Details
Table 142. Merck Business Overview
Table 143. Merck Antibody Conjugation and Labeling Services Product
Table 144. Merck Revenue in Antibody Conjugation and Labeling Services Business (2020-2025) & (US$ Million)
Table 145. Merck Recent Development
Table 146. Lonza Company Details
Table 147. Lonza Business Overview
Table 148. Lonza Antibody Conjugation and Labeling Services Product
Table 149. Lonza Revenue in Antibody Conjugation and Labeling Services Business (2020-2025) & (US$ Million)
Table 150. Lonza Recent Development
Table 151. Charles River Company Details
Table 152. Charles River Business Overview
Table 153. Charles River Antibody Conjugation and Labeling Services Product
Table 154. Charles River Revenue in Antibody Conjugation and Labeling Services Business (2020-2025) & (US$ Million)
Table 155. Charles River Recent Development
Table 156. Beijing Abace Biotechnology Company Details
Table 157. Beijing Abace Biotechnology Business Overview
Table 158. Beijing Abace Biotechnology Antibody Conjugation and Labeling Services Product
Table 159. Beijing Abace Biotechnology Revenue in Antibody Conjugation and Labeling Services Business (2020-2025) & (US$ Million)
Table 160. Beijing Abace Biotechnology Recent Development
Table 161. Research Programs/Design for This Report
Table 162. Key Data Information from Secondary Sources
Table 163. Key Data Information from Primary Sources
Table 164. Authors List of This Report


List of Figures
Figure 1. Antibody Conjugation and Labeling Services Picture
Figure 2. Global Antibody Conjugation and Labeling Services Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Antibody Conjugation and Labeling Services Market Share by Type: 2024 VS 2031
Figure 4. Antibody Conjugation Services Features
Figure 5. Antibody Labeling Services Features
Figure 6. Global Antibody Conjugation and Labeling Services Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Antibody Conjugation and Labeling Services Market Share by Application: 2024 VS 2031
Figure 8. Biotechnology Case Studies
Figure 9. Medical Case Studies
Figure 10. University Case Studies
Figure 11. Others Case Studies
Figure 12. Antibody Conjugation and Labeling Services Report Years Considered
Figure 13. Global Antibody Conjugation and Labeling Services Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Antibody Conjugation and Labeling Services Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Antibody Conjugation and Labeling Services Market Share by Region: 2024 VS 2031
Figure 16. Global Antibody Conjugation and Labeling Services Market Share by Players in 2024
Figure 17. Global Top Antibody Conjugation and Labeling Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody Conjugation and Labeling Services as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Antibody Conjugation and Labeling Services Revenue in 2024
Figure 19. North America Antibody Conjugation and Labeling Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Antibody Conjugation and Labeling Services Market Share by Country (2020-2031)
Figure 21. United States Antibody Conjugation and Labeling Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Antibody Conjugation and Labeling Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Antibody Conjugation and Labeling Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Antibody Conjugation and Labeling Services Market Share by Country (2020-2031)
Figure 25. Germany Antibody Conjugation and Labeling Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Antibody Conjugation and Labeling Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Antibody Conjugation and Labeling Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Antibody Conjugation and Labeling Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Antibody Conjugation and Labeling Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Antibody Conjugation and Labeling Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Antibody Conjugation and Labeling Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Antibody Conjugation and Labeling Services Market Share by Region (2020-2031)
Figure 33. China Antibody Conjugation and Labeling Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Antibody Conjugation and Labeling Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Antibody Conjugation and Labeling Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Antibody Conjugation and Labeling Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Antibody Conjugation and Labeling Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Antibody Conjugation and Labeling Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Antibody Conjugation and Labeling Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Antibody Conjugation and Labeling Services Market Share by Country (2020-2031)
Figure 41. Mexico Antibody Conjugation and Labeling Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Antibody Conjugation and Labeling Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Antibody Conjugation and Labeling Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Antibody Conjugation and Labeling Services Market Share by Country (2020-2031)
Figure 45. Turkey Antibody Conjugation and Labeling Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Antibody Conjugation and Labeling Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Antibody Conjugation and Labeling Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. ProSci, Inc Revenue Growth Rate in Antibody Conjugation and Labeling Services Business (2020-2025)
Figure 49. Thermo Fisher Scientific Revenue Growth Rate in Antibody Conjugation and Labeling Services Business (2020-2025)
Figure 50. Abcam Revenue Growth Rate in Antibody Conjugation and Labeling Services Business (2020-2025)
Figure 51. Cell Signaling Technology Revenue Growth Rate in Antibody Conjugation and Labeling Services Business (2020-2025)
Figure 52. Bio X Cell Revenue Growth Rate in Antibody Conjugation and Labeling Services Business (2020-2025)
Figure 53. SouthernBiotech Revenue Growth Rate in Antibody Conjugation and Labeling Services Business (2020-2025)
Figure 54. Novus Biologicals Revenue Growth Rate in Antibody Conjugation and Labeling Services Business (2020-2025)
Figure 55. GenScript Revenue Growth Rate in Antibody Conjugation and Labeling Services Business (2020-2025)
Figure 56. Leinco Technologies Revenue Growth Rate in Antibody Conjugation and Labeling Services Business (2020-2025)
Figure 57. Standard BioTools Revenue Growth Rate in Antibody Conjugation and Labeling Services Business (2020-2025)
Figure 58. AlphaThera Revenue Growth Rate in Antibody Conjugation and Labeling Services Business (2020-2025)
Figure 59. Creative Biolabs Revenue Growth Rate in Antibody Conjugation and Labeling Services Business (2020-2025)
Figure 60. Antibodies Revenue Growth Rate in Antibody Conjugation and Labeling Services Business (2020-2025)
Figure 61. Boster Biological Technology Revenue Growth Rate in Antibody Conjugation and Labeling Services Business (2020-2025)
Figure 62. Cygnus Technologies Revenue Growth Rate in Antibody Conjugation and Labeling Services Business (2020-2025)
Figure 63. Cayman Chemical Revenue Growth Rate in Antibody Conjugation and Labeling Services Business (2020-2025)
Figure 64. GeneTex Revenue Growth Rate in Antibody Conjugation and Labeling Services Business (2020-2025)
Figure 65. ProteoGenix Revenue Growth Rate in Antibody Conjugation and Labeling Services Business (2020-2025)
Figure 66. Levena Biopharma Revenue Growth Rate in Antibody Conjugation and Labeling Services Business (2020-2025)
Figure 67. Merck Revenue Growth Rate in Antibody Conjugation and Labeling Services Business (2020-2025)
Figure 68. Lonza Revenue Growth Rate in Antibody Conjugation and Labeling Services Business (2020-2025)
Figure 69. Charles River Revenue Growth Rate in Antibody Conjugation and Labeling Services Business (2020-2025)
Figure 70. Beijing Abace Biotechnology Revenue Growth Rate in Antibody Conjugation and Labeling Services Business (2020-2025)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies